Risk of venous thromboembolism in users of contraception and menopausal hormone therapy during the COVID-19 pandemic.

In this scenario, apart from the fundamental orientations of preventive measures, like social isolation and hygiene, it is important that all female health professionals have knowledge of the new rules and adopt safety measures, especially on the prescription of hormonal therapy and contraception.